Thursday 7 June 2018
07:15-08:15
Amphitheatre
Inflammation in cystic fibrosis: the next frontier
Moderator: Stuart Elborn, London, UK
07:15 – 07:30 Pathophysiology of lung inflammation in CF – Marcus Mall, Berlin, DE 
07:30 –07:45Clinical trials addressing CF inflammation and their limitations – Jennifer Taylor-Cousar, Denver, US
07:45 – 07:50Current approaches – Stuart Elborn, London, UK 
07:50 – 08:05Design of acebilustat phase 2b study (EMPIRE CF) – Steven M. Rowe, Birmingham, US 
08:05 – 08:15Discussion and questions & answers

 Thursday 7 June 2018
12:30-14:00
Blue Hall
Shifting the paradigm in cystic fibrosis management: current and future
Moderator: Marcus Mall, Berlin, DE
12:30 – 12:45  Welcome and introduction – Marcus Mall, Berlin, DE
12:45 –13:05 Cystic fibrosis: navigating the disease trajectory – Claire Wainwright, Brisbane, AU
13:05 – 13:25 Current and future management strategies: the evidence – Jane Davies, London, UK
13:25 – 13:45 Future thinking: assessing effectiveness in practice – Barry Plant, Cork, IE
13:45 – 14:00 Questions & moderator’s close

Friday 8 June 2018
12:30-14:00
Amphitheatre
Making a difference in cystic fibrosis daily challenges
Moderator: Harry Heijerman, Utrecht, NL    
12:30 – 13:00 Preventing CF complications – Harry Heijerman, Utrecht, NL
13:00 –13:30Nebulized antibiotic therapy – yesterday and nowadays – Carsten Schwarz, Berlin, DE
13:30 – 14:00Dealing with the challenges of an ageing CF population – Stuart Elborn, London, UK

 Friday 8 June 2018
12:30-13:30
Annex B
From bench to bedside: Exploring in vitro in vivo correlation of CF models
Moderator: Mark Higgins, London, UK
12:30 – 12:40 Welcome and introduction – Mark Higgins, London, UK
12:40 –13:20Exploring the in vitro / in vivo correlation of CF models – Paul Negulescu, San Diego, USA
13:20 – 13:30Questions & moderator’s close